- Home
- ULBI vs CLYM Comparison
ULBI vs CLYM Comparison
Compare ULBI & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- CLYM
- Stock Information
- Founded
- ULBI 1990
- CLYM 2018
- Country
- ULBI United States
- CLYM United States
- Employees
- ULBI N/A
- CLYM N/A
- Industry
- ULBI Industrial Machinery/Components
- CLYM
- Sector
- ULBI Miscellaneous
- CLYM
- Exchange
- ULBI Nasdaq
- CLYM NYSE
- Market Cap
- ULBI 98.1M
- CLYM 86.5M
- IPO Year
- ULBI 1992
- CLYM 2021
- Fundamental
- Price
- ULBI $8.21
- CLYM $1.22
- Analyst Decision
- ULBI Strong Buy
- CLYM Buy
- Analyst Count
- ULBI 1
- CLYM 1
- Target Price
- ULBI $14.00
- CLYM $10.00
- AVG Volume (30 Days)
- ULBI 127.1K
- CLYM 204.9K
- Earning Date
- ULBI 07-24-2025
- CLYM 08-13-2025
- Dividend Yield
- ULBI N/A
- CLYM N/A
- EPS Growth
- ULBI N/A
- CLYM N/A
- EPS
- ULBI 0.31
- CLYM N/A
- Revenue
- ULBI $173,275,000.00
- CLYM N/A
- Revenue This Year
- ULBI $31.30
- CLYM N/A
- Revenue Next Year
- ULBI $6.24
- CLYM N/A
- P/E Ratio
- ULBI $26.11
- CLYM N/A
- Revenue Growth
- ULBI 2.74
- CLYM N/A
- 52 Week Low
- ULBI $4.07
- CLYM $1.05
- 52 Week High
- ULBI $12.40
- CLYM $9.21
- Technical
- Relative Strength Index (RSI)
- ULBI 70.78
- CLYM N/A
- Support Level
- ULBI $7.37
- CLYM N/A
- Resistance Level
- ULBI $8.53
- CLYM N/A
- Average True Range (ATR)
- ULBI 0.42
- CLYM 0.00
- MACD
- ULBI 0.02
- CLYM 0.00
- Stochastic Oscillator
- ULBI 81.16
- CLYM 0.00
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.